Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
By Songping Cui, Shuo Chen, Xiunan Li, Shi Liu, Feng Wang. Journal of Thrombosis and Haemostasis, 2020
1,663 citations recorded by the source corpus.
Three months ago, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) broke out in Wuhan, China, and spread rapidly around the world. Severe novel coronavirus pneumonia (NCP) patients have abnormal blood coagulation function, but their venous thromboembolism (VTE) prevalence is still rarely mentioned.
Subfields: Infectious Diseases, Internal Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/9be02ba5e5b52a3ae0ba95def97526901713ac36
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Internal Medicine
In Surgery
Citations in the corpus
- COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection (2020, neutral): “6,7 The high venous thromboembolism (VTE) rates reported in these early studies have prompted some investigators to recommend empiric escalation of anticoagulation doses used for prophylaxis in COVID-19 patients.”
- High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients (2020, neutral): “2) Male sex 20 (77) 6 (75) 14 (78) Chronic medical condition Active cancer 0 (0) 0 (0) 0 (0) Previous VTE 1 (4) 0 (0) 1 (6) Arterial hypertension 22 (85) 7 (87) 15 (83) Tobacco 7 (27) 2 (25) 5 (28) Surgery < 3 months 1 (4) 0 (0) 1 (6) Anticoagulation before admission 7 (27) 0 (0) 7 (39) .”
- Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis (2020, neutral): “Fifty (50) studies were reviewed in full text and 42 studies [4 (cid:1) 7,9,10,16 (cid:1) 51] enrolling 8271 patients were eventually included in the meta-analysis.”
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy (2020, neutral): “According to a Chinese study, the prevalence of VTE was 25% with routine VTE screening, although details on the type and timing of screening were not provided [11].”
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020, background): “Of note, none of the patients had received VTE prophylaxis (85).”